1stOncology™: Cancer Intelligence Service – Page 15606 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Jounce Therapeutics to Present at Cowen and Company 38th Annual Health Care Conference

On March 5, 2018 Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers for patient enrichment, reported that Richard Murray, Ph.D., chief executive officer and president of Jounce, will present at the Cowen and Company 38th Annual Health Care Conference on Monday, March 12, 2018 at 4:50 PM ET in Boston, MA (Press release, Jounce Therapeutics, MAR 5, 2018, View Source;p=RssLanding&cat=news&id=2336132 [SID1234524972]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

A live webcast of the presentation will be available by visiting "Events and Presentations" in the Investors and Media section of Jounce’s website at www.jouncetx.com. A replay of the webcast will be archived for 30 days following the presentation.

Can-Fite to Present at the Inaugural LD Micro Virtual Conference

On March 5, 2018 Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small-molecule drugs that address cancer, liver disease and inflammatory diseases, reported that it will be presenting at the inaugural LD Micro Virtual Conference on Tuesday, March 6, 2018 at 8:30 AM PST (Press release, Can-Fite BioPharma, MAR 5, 2018, View Source [SID1234524642]). Can-Fite CEO, Dr. Pnina Fishman, will be delivering a corporate presentation and conducting a Q&A session with the investment community.

The conference will be held via webcast and will feature over 60 companies in the small / micro-cap space.

Bristol-Myers Squibb to Take Part in Cowen and Company 38th Annual Global Health Care Conference

On March 5, 2018 -Bristol-Myers Squibb Company (NYSE:BMY) reported that participate in the Cowen and Company 38th Annual Global Health Care Conference on Monday, March 12, 2018, in Boston (Press release, Bristol-Myers Squibb, MAR 5, 2018, https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-take-part-cowen-and-company-38th-annual-g [SID1234524640]). Giovanni Caforio, chairman and chief executive officer and Fouad Namouni, head of oncology development will answer questions about the company at 2:50 p.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at View Source An archived edition of the session will be available later that day.

Apollo Endosurgery, Inc. to Participate at the 30th Annual ROTH Conference

On March 5, 2018 Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, reported that Company management is scheduled to present at the 30th Annual ROTH Conference being held March 11-14, 2018 at the Ritz-Carlton Laguna Niguel in Orange County, CA. The presentation is scheduled for Monday, March 12, 2018 at 11:00 am PT (Press release, , MAY 5, 2018, https://www.thestreet.com/newsletters [SID1234524626]).

Cytokinetics to Present at March Investor Conferences

On March 5, 2018 Cytokinetics, Incorporated (Nasdaq:CYTK) reported that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at the following investor conferences (Press release, , MAY 5, 2018, View Source [SID1234524622]):

Cowen and Company 38th Annual Health Care Conference on Monday, March 12, 2018 at 2:50 PM EST at the Boston Marriott Copley Place Hotel in BostonInterested parties may access the live webcast of this presentation by visiting the Investors & Media section of the Cytokinetics website at www.cytokinetics.com. The webcast replay of the presentation will be archived on the Presentations page within the Investors & Media section of Cytokinetics’ website for 90 days following the conclusion of the event.